September 23, 2026 - 05:22

Atlanticus Holdings Corporation has finalized the sale of its entire Auto Finance segment, known as CAR, to an unaffiliated buyer. The transaction was announced on September 17 and carries a total consideration of approximately 71.2 million dollars. This figure includes 56.2 million dollars in cash along with a 15 million dollar seller note.
The company intends to direct the cash proceeds toward reducing debt and funding other investments. This move marks a significant shift in the firm's operational focus as it exits the auto lending business entirely.
The central question now is whether Atlanticus can offset the earnings previously generated by the auto finance unit. That segment had contributed meaningfully to overall revenue, and its removal leaves a gap that management must fill through other business lines. The company's core credit offerings and consumer finance products will need to perform strongly to compensate for the lost contribution.
Investors will watch upcoming quarterly reports closely to see how effectively the remaining operations absorb the impact. Cost savings from the divestiture may help, but replacing the income stream outright remains a challenge. The seller note also introduces some deferred payment risk depending on the buyer's performance.
For now, the debt reduction provides some balance sheet relief. Whether that translates into stronger shareholder value over time depends on execution across the rest of the portfolio.
September 22, 2026 - 17:57
Finance Committee backs 4-year 1% sales tax continuation; final decision up to Nov. votersCHEYENNE, Wyo. - A four-year continuation of the City of Cheyenne`s optional 1% sales tax is a step closer to appearing on the November ballot after the Finance Committee backed the measure during...
September 22, 2026 - 00:45
Meta stock jumps as Wells Fargo raises price targetMeta shares surged more than 10 percent during trading after Wells Fargo raised its price target on the stock from $640 to $796. The significant bump in the target price reflects growing confidence...
September 21, 2026 - 00:49
LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible...
September 20, 2026 - 02:49
Why Xenon Pharmaceuticals (XENE) Is Down 32.2% After Pausing Psychiatry Trials Despite Positive NDA DataXenon Pharmaceuticals saw its stock drop 32.2 percent after the company paused new enrollment in its Phase 3 trials for major depressive disorder and bipolar depression. The decision came on the...